|
EPC2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.423200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.517900E-02 |
| Normal-vs-Stage2 |
7.605400E-01 |
| Normal-vs-Stage3 |
1.850470E-02 |
| Normal-vs-Stage4 |
4.607100E-04 |
| Stage1-vs-Stage2 |
1.690030E-01 |
| Stage1-vs-Stage3 |
1.248350E-04 |
| Stage1-vs-Stage4 |
2.57459999986054E-07 |
| Stage2-vs-Stage3 |
1.787400E-01 |
| Stage2-vs-Stage4 |
3.575900E-02 |
| Stage3-vs-Stage4 |
2.213400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.474000E-01 |
| Normal-vs-AfricanAmerican |
1.523380E-01 |
| Normal-vs-Asian |
3.207600E-01 |
| Caucasian-vs-AfricanAmerican |
1.693000E-01 |
| Caucasian-vs-Asian |
1.717410E-01 |
| AfricanAmerican-vs-Asian |
1.057240E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.065400E-01 |
| Normal-vs-Female |
8.202600E-01 |
| Male-vs-Female |
2.045600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.697000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.100000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.584200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.857700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.331800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.272200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.798440E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.142030E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.406100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.324220E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.043600E-02 |
| Normal-vs-Grade 2 |
3.665500E-02 |
| Normal-vs-Grade 3 |
3.917800E-02 |
| Normal-vs-Grade 4 |
1.98712999999184E-05 |
| Grade 1-vs-Grade 2 |
1.796380E-01 |
| Grade 1-vs-Grade 3 |
8.169000E-04 |
| Grade 1-vs-Grade 4 |
1.8774499999985E-05 |
| Grade 2-vs-Grade 3 |
1.72361999999371E-05 |
| Grade 2-vs-Grade 4 |
2.51749998625428E-09 |
| Grade 3-vs-Grade 4 |
2.678800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.640500E-03 |
| Normal-vs-ccB subtype |
6.186100E-02 |
| ccA subtype-vs-ccB subtype |
6.48979999962052E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.274200E-01 |
| Normal-vs-N1 |
3.837700E-02 |
| N0-vs-N1 |
5.755800E-02 |
|
|
